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The long recognized neurotibrillary immunoreactivity of the nervous system with a-MSH antibodies arises 
from an epitope on neurofilament M-protein which we have now characterized. It is situated in the amino 
terminal residues where M-protein and CC-MSH exhibit similar but not identical sequences. Their divergence 
past residue 5 precludes a physiological significance of the crossreactivity which seems to have arisen fortui- 
tously. Our results question previous speculations as to the existence of extrapituitary a-MSH-like hor- 
mones. 
u-MSH Neuropeptide Neurofilament 
1. INTRODUCTION 
The main source of a-melanocyte-stimulating 
hormone (a-MSH), an acetyl-tridecapeptide 
amide, is the pituitary gland where it is processed 
from a large polyprotein precursor [l]. However, 
many studies dating back at least to 1977 
documented strong neurofibrillary cu-MSH im- 
munoreactivity in most parts of the nervous system 
(see, e.g., [2-61). Radioimmunoassays were used 
to quantitate this material and various speculations 
as to extrapituitary u-MSH-related hormones have 
been advanced. The neurofibrillary specificity of 
the reaction was partially explained when Drager et 
al. [2] found that cu-MSH antibodies stain 
neurofilaments, the neuronal form of intermediate 
filaments. Immunoblotting revealed reactivity only 
for the middle-sized M-protein, one of the three 
filament components: L (68 kDa), M (160 kDa), 
and H (200 kDa) [7]. This and previous observa- 
tions [2-61 raised the possibility that neurofila- 
ments may contain peptide hormone-like se- 
quences, and we note that intermediate filament 
proteins have been postulated to be related to 
Neuron Epitope Crossreactivitv 
steroid hormone receptors [8]. With the recent 
availability of partial neurofilament protein se- 
quences [9, IO], we felt in a good position to follow 
up these earlier findings. 
2. MATERIALS AND METHODS 
Chicken desmin, porcine neurofilament M- 
protein, and fragments of M covering residues 
l- 102 (headpiece) and the carboxy-terminal 
tailpiece extension were isolated [9, lo]. Rabbit an- 
tiserum to a-MSH was obtained from Im- 
munonuclear Corp. (Stillwater, MN, USA). Initial 
studies used lot no.31261 as in [2]. As this serum 
was later not available we made use of lot no. 
8410018. Competitive ELISA between immobi- 
lized M-protein, a-MSH antibody and various 
peptides was performed as described for another 
antigen-antibody system [ 111. Western blotting 
was performed as in [12]. Peroxidase-conjugated 
second antibodies were used. a-MSH, desacetyl cy- 
MSH, ACTH, ACTHI-10, and the tetrapeptide S- 
Y-S-M were from Bachem (Bubendorf, 
Switzerland). Serine-tyrosine was obtained from 
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Serva. Acetylation was performed with acetic 
anhydride using standard techniques. Acetylated 
peptides were purified by HPLC and characterized 
by amino acid composition and electrophoresis. 
Tobacco mosaic virus (TMV) coat protein and a 
rabbit antiserum known to react with the amino- 
terminal 10 residues of this protein [ 131 were kind- 
ly donated by Dr Van Regenmortel, CNRS, 
Strasbourg, France. Sequences are given using the 
one-letter system. AC refers to the N-acetyl group. 
3. RESULTS AND DISCUSSION 
Fig.1 confirms the specific recognition of por- 
cine neurofilament M-protein by anti-cY-MSH 
serum reported by Drager et al. [2]. Current se- 
quence data on porcine M-protein do not cover the 
large carboxy-terminal CNBr fragment (tailpiece) 
although the amino-terminal 436 residues are 
known [9]. Western blots of cyanogen bromide- 
cleaved M-protein showed no reactivity of the 
large carboxy-terminal fragment or the fragment 
corresponding to residues 68-285 (fig. 1). Strong 
decoration of an 8-kDa fragment indicated the 
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Fig.1. Lanes 1-6, 12.5% polyacrylamide g l (l-3) and 
corresponding Western blot (4-6) of purified 
neurofilament proteins (H, M and L), M-protein tail 
piece (t) and M-protein head piece (h) with cu-MSH 
antibody. Both the intact protein (lanes 1 and 4) and the 
small amino-terminal moiety (lanes 3 and 6) are strongly 
stained. Lanes 7-12, 10% polyacrylamide gel (7-9) and 
corresponding Western blot (10-12) of TMV coat 
protein (TMV), neurofilament M-protein (M), and 
chicken desmin (D). Blot was stained with m-MSH 
antibody. CI-MSH antibody recognizes M and TMV, but 
not chicken desmin. 
amino-terminal fragment (residues l-67) which 
was corroborated using a pure preparation of a 
proteolytic fragment covering residues 1- 102 
(headpiece). Having localized the a-MSH-like an- 
tigen to residues l-67, a sequence comparison with 
a-MSH indicated only one candidate for a con- 
tinuous epitope, i.e., the amino-terminal residues. 
These are AC-S-Y-T-L-D- and AC-S-Y-S-M-E- in 
M-protein and (Y-MSH, respectively (see table 1). 
A modified ELISA with carrier-bound porcine 
M-protein was used to test various peptides for an- 
tigen competition. cu-MSH consists of the first 13 
residues of ACTH but is acetylated at the amino 
terminus and amidated at the carboxyl end. The 
much lower reactivity of ACTH and desacetylated 
a-MSH in comparison to cu-MSH implicated the 
acetylated end. The amino-terminal tetrapeptide S- 
Y-S-M displayed very poor competition under our 
assay conditions, whereas its N-acetyl derivative 
showed significant reaction (table 1). The N- 
acetylated ipeptide S-Y exhibited slight inhibition 
at very high concentrations, though S-Y alone 
showed no inhibition. Acetylated ACTHi- 10 in- 
hibited about as strongly as LU-MSH, whereas the 
non-acetylated form inhibited much more weakly. 
Both lots of a-MSH antibody we examined be- 
haved in an almost identical manner in these ex- 
periments. A previous study made use of four dif- 
ferent LU-MSH antisera, all of which exhibited 
staining of non-pituitary structures [6], suggesting 
that many a-MSH antibodies may be able to 
recognize the M-protein. 
Purified chicken desmin (fig.1, table 1) is not 
recognized, indicating a requirement for tyrosine 
at position 2. The combined results suggest hat 
strong antibody binding requires acetyl-serine- 
tyrosine, followed by at least two and preferably 
more amino acids the identity of which can, at 
least within limits, be somewhat variable. The 
identification of the antigenic site on the M-protein 
explains the neuronal specificity of a-MSH stain- 
ing seen in histological samples, since various in- 
termediate filament [9] and other cytoskeletal pro- 
teins (see below) differ from M in their amino- 
terminal sequence [9]. 
We searched the National Biomedical Research 
Foundation protein sequence data bank for other 
proteins exhibiting an acetylated amino-terminal 
serine followed by a tyrosine and a serine or 
threonine. This requirement was fulfilled by TMV 
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Summary of results from competitive ELISA and Western blotting experiments 
Peptide used in competitive ELISA Concentration required 
for 50% inhibition 
S-Y > 333 pMa 
AC-S-Y 300 pM 
S-Y-S-M (ACTHi-4) > 100 pMa 
AC-S-Y-S-M (acetylated ACTHr-4) 235 nM 
S-Y-S-M-E-H-F-R-W-G-K-P-V-amide (desacetyl a-MSH) 60pM 
Ac-S-Y-S-M-E-H-F-R-W-G-K-P-V-amide (LY-MSH) 380 pM 
N-terminus of protein used in Result of Western 
Western blotting experiments blotting experiment 
AC-S -Y-T-L -D-S -L-G-N-P-S -S -A.. . (M protein) +++ 
AC-S -Y-S -I -T -T-P -S -Q-F -V-F -L . . . (TMV coat protein) +++ 
AC-S -Q-S -Y-S -S -S -Q-R-V-S -S -Y . , . (chicken desmin) _ 
a The peptide failed to reach 50% inhibition at the highest concentration employed 
coat protein. The sequence AC-S-Y-S-I-T- [14,15] 
shows good homology to (u-MSH and M-protein 
for the first four residues. Western blotting (fig. 1) 
revealed that TMV coat protein was also reactive 
with a-MSH antibodies. In addition, a rabbit an- 
tiserum known to recognize the amino-terminal 10 
residues of coat protein [13] recognizes M-protein 
on Western blots, although very weakly (not 
shown). 
The amino-terminal region of TMV coat protein 
belongs to the increasing list of linear or con- 
tinuous epitopes thought to be prime antigenic 
targets because of their segmental mobility as 
revealed by X-ray crystallography [ 13,161. Such 
sites are very often situated in loops and can also 
occur at the termini of different proteins 
[ 11,13,16]. Current concepts of intermediate fila- 
ment structure based on biochemical and sequence 
considerations already suggest the presence of 
loops in the amino-terminal region of M-protein as 
in other intermediate filament proteins [9, lo]. The 
crossreactivity of a-MSH antibodies documented 
here confirms the general principle of a linear 
epitope situated in a flexible loop at the amino- 
terminal end. Tolerable sequence variations in this 
region account for the crossreactivity of the cy- 
MSH antibodies with proteins as divergent as LY- 
MSH, neurofilament M-protein, and TMV coat 
protein. As the sequence relationship between cy- 
MSH and neurofilament M-protein is lost past 
residue 5 (see table 1) we conclude that neurofila- 
ment proteins cannot serve as a precursor or 
storage form of a-MSH-like hormones. This 
should lay to rest previous speculations on ex- 
trapituitary a-MSH-like hormones in the nervous 
system [3-61 based solely on immunological 
crossreactivity. 
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